Published literature, mechanisms, and protocols, organized by compound. Educational reference, not medical advice.
A sourcing reference for kisspeptin-10 (KP-10): why C-terminal amidation and Trp-3 integrity drive its synthesis, purification, and analytical verification standards. Educational reference.
A source-attributed summary of kisspeptin-10 (KP-10) research, tracing the compound from KISS1R receptor pharmacology and structure-activity mapping through KNDy-neuron circuitry to controlled human neuroendocrine studies and open questions. Educational reference.
How a melanoma metastasis-suppressor gene named in Hershey, Pennsylvania yielded KP-10, the ten-residue RF-amide fragment that deorphanized GPR54. A structure- and discovery-driven reference on kisspeptin-10. Educational reference.
A mechanistic reference on kisspeptin-10 at KISS1R, tracing the RFamide pharmacophore, Gq/11-phospholipase C signaling, TRPC-mediated depolarization, and GnRH neuron firing described across primary neuroendocrine literature. Educational reference.
How kisspeptin-10 traveled from a 1996 cancer-metastasis gene named in Hershey to the 2001 GPR54 deorphanization and the 2003 puberty-genetics findings that founded a field. Educational reference.
A sourcing and quality reference for ipamorelin: solid-phase synthesis of its Aib and D-2-Nal residues, C-terminal amidation, HPLC and mass-spec verification, counterion salt forms, and batch documentation. Educational reference.
A source-by-source survey of ipamorelin's peer-reviewed literature, traced from the 1998 Novo Nordisk discovery papers through the ghrelin-mimetic gastrointestinal program and a phase 2 postoperative-ileus trial. Educational reference.
Ipamorelin traced from a research angle: how a GHRP-1-derived pentapeptide came to be described as the first selective growth hormone secretagogue, its GHS-R1a classification, discovery lineage at Novo Nordisk, and RUO regulatory standing.
A mechanism-focused review of ipamorelin at the GHS-R1a receptor: the Gq/phospholipase C pathway, calcium-triggered somatotroph exocytosis, and the pharmacological selectivity reported by its discoverers. Educational reference.
Tracing ipamorelin from the 1970s GHRP tradition through its 1998 characterization at Novo Nordisk, the ghrelin discovery that redefined its target, its postoperative-ileus clinical program, and the FDA 503A compounding review. Educational reference.
Why IGF-1 LR3's 83-residue sequence, three disulfide bonds, and ~9,111 Da mass shape its recombinant manufacturing, refolding, and analytical verification. Educational reference.
A structured bibliographic review of the peer-reviewed IGF-1 LR3 literature, organized by the analog's distinguishing pharmacology: reduced IGFBP binding, its use in rodent potency comparisons, and its adoption as a serum-free cell-culture supplement. Educational reference.
Why two deliberate changes to the IGF-1 sequence, an N-terminal extension and an Arg-3 substitution, produced a research reagent that engages IGF-1R while escaping the binding-protein family. Educational reference.
A mechanism reference on IGF-1 LR3: IGF-1R engagement at the insulin-receptor-superfamily interface, the free-peptide consequence of reduced IGFBP affinity, and the reported PI3K/Akt and MAPK/ERK signaling branches downstream of receptor activation. Educational reference.
IGF-1 LR3 was engineered by deliberately weakening one binding interaction while preserving another. This history traces the somatomedin hypothesis, the Rinderknecht-Humbel sequencing work, the Adelaide analog program behind Long R3 IGF-1, and its footing as a research reagent. Educational reference.
Why hexarelin's two D-amino-acid residues make stereochemical control and mass-spectrometric identity confirmation central to its sourcing and quality verification. Educational reference.
A structured survey of the hexarelin research literature, organized around its GH-releasing pharmacology and the CD36-linked cardiovascular, metabolic, and neuroprotective models that have shaped later work. Educational reference.
A research-library profile of hexarelin (examorelin): the hexapeptide's D-2-methyltryptophan chemistry, its position in the GHRP secretagogue lineage, dual GHS-R1a and CD36 binding described in the literature, and its Phase II development history. Educational reference.
A mechanistic reference on hexarelin's unusual two-receptor pharmacology: GHS-R1a-driven calcium and MAPK signaling versus CD36-mediated PPARgamma transcription, and where the two cascades converge on cell-survival endpoints in preclinical research.
A chronological history of hexarelin: its origin in the Bowers GHRP lineage, Deghenghi's early-1990s synthesis, human endocrine characterization at Turin, the GHS-R1a and CD36 receptor milestones, and its Phase II regulatory arc.
A sourcing reference for glutathione (GSH): biotechnological fermentation and synthetic routes, the redox-active thiol, GSH/GSSG state, and the analytical methods that verify identity, purity, and oxidation. Educational reference.
A structured review of peer-reviewed glutathione research, organized by the questions each body of work set out to answer: biosynthesis and pool size, intracellular compartmentalization, GPx enzymatic chemistry, S-glutathionylation signaling, and controlled oral-supplementation trials.
An educational overview of glutathione (GSH): the atypical gamma-glutamyl bond, cysteine thiol reactivity, the GSH/GSSG couple, two-step ATP-dependent biosynthesis, and how the tripeptide was characterized. Educational reference.
A mechanism-focused account of glutathione (GSH): how its central cysteine thiol drives the GSH/GSSG couple, powers glutathione peroxidase and transferase catalysis, and forms reversible protein mixed disulfides in redox signaling. Educational reference.
How glutathione went from an unnamed reducing substance in 1888 yeast extracts to a fully mapped tripeptide with three enzyme families and a redox-signaling role, told through the investigators who defined it. Educational reference.
A sequence-specific look at how the hexapeptide GHRP-6 is manufactured and analytically verified, from solid-phase synthesis of its D-residues to HPLC and mass-spectrometry identity confirmation. Educational reference.
A citation-based survey of the published GHRP-6 literature, tracing the peptide from its 1984 pharmacological characterization through the cloning of its receptor and the discovery of ghrelin. Educational reference.
An educational overview of GHRP-6, the founding peptidyl growth hormone secretagogue: its enkephalin-derived hexapeptide chemistry, GHS-R1a classification, and the discovery record that preceded ghrelin. Educational reference.
How the published literature describes GHRP-6 at the molecular level: full agonism at the ghrelin receptor GHS-R1a, its distinctive inverted binding orientation resolved by cryo-EM, the Gq/PLC calcium cascade in pituitary somatotrophs, and its separate CD36 scavenger-receptor interactions.
How a hexapeptide from a 1970s opioid laboratory became the founding growth hormone secretagogue and a decade-long probe of the then-unknown ghrelin receptor system.
A sourcing reference for GHRP-2 (pralmorelin): its unnatural D-amino-acid sequence, why chirality and 2-naphthylalanine complicate synthesis, and the analytical methods used to confirm identity and purity. Educational reference.
A bibliographic review of peer-reviewed GHRP-2 (pralmorelin) research, organized by the research communities that studied it: receptor pharmacology, human neuroendocrine work, the Japanese diagnostic dossier, and anti-doping detection chemistry. Educational reference.
GHRP-2 (pralmorelin, KP-102) is a synthetic hexapeptide growth hormone secretagogue defined by its D-2-naphthylalanine residue. This overview traces its chemistry, ghrelin-receptor pharmacology, and status as the first GHS approved for diagnostic use in Japan. Educational reference.
A mechanism-focused reference on GHRP-2 (pralmorelin): its D-amino-acid hexapeptide design, agonism at the GHS-R1a ghrelin receptor, the Gq/11-phospholipase C calcium cascade in pituitary somatotrophs, and its documented synergy with GHRH. Educational reference.
A chronological history of GHRP-2 (pralmorelin, KP-102): its origins in enkephalin chemistry, its derivation from the GHRP-6 hexapeptide via D-2-naphthylalanine substitution, and the reverse-pharmacology arc from receptor cloning to ghrelin's discovery.
Why GHK-Cu quality control turns on the copper-coordination step: peptide synthesis, 1:1 stoichiometry confirmation, spectroscopic identity, and batch documentation. Educational reference.
A citation-organized walkthrough of the GHK-Cu research record, from the 1973 serum-fraction isolation through fibroblast collagen assays, the 1994 wound-chamber study, and later transcriptomic and pulmonary-model work. Educational reference.
GHK-Cu is the copper(II) complex of the plasma tripeptide glycyl-histidyl-lysine. This reference examines its coordination chemistry, its origin as a collagen fragment, how it is classified in the literature, and its regulatory standing. Educational reference.
A mechanism-focused review of GHK-Cu built around its copper(II) coordination chemistry: the tripeptide binding site, the copper-shuttle hypothesis, reported extracellular-matrix effects, and transcriptomic profiling in the peer-reviewed literature. Educational reference.
How GHK-Cu moved from an unnamed serum activity in a 1973 liver-cell assay to a defined copper-binding tripeptide, traced through the primary literature and its cosmetic-ingredient regulatory path. Educational reference.
A quality-focused reference on Epithalon (AEDG): why its acidic four-residue sequence shapes synthesis, purification, and analytical verification. Educational reference.
A source-organized survey of the Epithalon (AEDG tetrapeptide) and Epithalamin extract literature, separating cell-culture telomerase and chromatin work from rodent lifespan experiments and long-term human observational cohorts, with the documented gaps noted. Educational reference.
How the four-residue AEDG sequence was isolated from the pineal extract Epithalamin, why the Khavinson "short peptide bioregulator" framework matters, and where the telomerase and regulatory literature actually stands. Educational reference.
How the peer-reviewed literature describes the reported molecular activity of the Epithalon (AEDG) tetrapeptide, from telomerase and hTERT induction to chromatin decondensation, computational histone docking, and pineal neuroendocrine signaling in cell and animal models. Educational reference.
A source-anchored timeline of Epithalon (AEDG): the 1970s Leningrad pineal program, the Epithalamin extract era, the 2017 mass-spectrometry identification of the tetrapeptide, and the 2025 independent-replication turn. Educational reference.
A sourcing and quality reference for CJC-1295 without DAC (Modified GRF 1-29): the four sequence modifications, SPPS synthesis considerations, analytical verification, and storage of the lyophilized peptide. Educational reference.
A research-library map of how the fragmented GHRH-analog literature (the tetrasubstituted GRF(1-29) backbone, sermorelin, and the DAC-bearing variant) applies to CJC-1295 without DAC, with each study's scope flagged. Educational reference.
An educational overview of CJC-1295 without DAC (Modified GRF 1-29): the four amino acid substitutions that resist DPP-4 cleavage, how it differs from the DAC-bearing variant, and the regulatory history of its GRF(1-29) scaffold.
A mechanism review of CJC-1295 without DAC (Mod GRF 1-29): GHRH-receptor pharmacology, the Gαs/cAMP/PKA cascade, and why its four substitutions target DPP-4 metabolism rather than receptor binding. Educational reference.
How CJC-1295 without DAC (Mod GRF 1-29) came to be: the 1982 isolation of GHRH, the DPP-4 degradation problem, and the four substitutions that define its scaffold. Educational reference.
